Cancer cells with low expression of the core system xc–/GPX4 pathway are more likely to depend on the CoQ10 or other antioxidant systems, making them vulnerable to inhibiting GPX4-independent ferroptosis defense systems [27]. This evidence concerns the gene GPX4 and cancer.